These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15007152)

  • 1. Joint pain and hyperalgesia due to pyridostigmine bromide in a patient with myasthenia gravis.
    Rostedt A; Stålberg E
    Neurology; 2004 Mar; 62(5):835-6. PubMed ID: 15007152
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyridostigmine-induced dystonic blepharospasm in a patient with ocular myasthenia gravis.
    Voon YC; Yahya WN; Hasan S; Ibrahim NM
    Mov Disord; 2010 Jul; 25(9):1299-300. PubMed ID: 20629121
    [No Abstract]   [Full Text] [Related]  

  • 3. Anaphylaxis by pyridostigmine.
    Castellano A; Cabrera M; Robledo T; Martinez-Cócera C; Cimarra M; Llamazares AA; Chamorro M
    Allergy; 1998 Nov; 53(11):1108-9. PubMed ID: 9860251
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyridostigmine-induced microcephaly.
    Polizzi A; Ruggieri M; Vincent A
    Neurology; 2001 Jun; 56(11):1606-7. PubMed ID: 11409415
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyridostigmine-induced microcephaly.
    Al-Shekhlee A; Robin N; Kaminski HJ
    Neurology; 2001 Jun; 56(11):1606-7. PubMed ID: 11402134
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy of myasthenic crisis.
    Mayer SA; Thomas CE
    Crit Care Med; 1998 Jun; 26(6):1136-7. PubMed ID: 9635669
    [No Abstract]   [Full Text] [Related]  

  • 7. Pyridostigmine-induced microcephaly.
    Niesen CE; Shah NS
    Neurology; 2000 May; 54(9):1873-4. PubMed ID: 10802806
    [No Abstract]   [Full Text] [Related]  

  • 8. Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial.
    Sieb JP; Köhler W
    Clin Neurol Neurosurg; 2010 Nov; 112(9):781-4. PubMed ID: 20663605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridostigmine Suicidal Attempt in a Myasthenia Gravis Patient.
    Malabaey MAT; Al-Saud AA; Alaska YA; Almas A; Malik A
    Am J Case Rep; 2019 Sep; 20():1418-1421. PubMed ID: 31554781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocytoclastic Vasculitis Secondary to Pyridostigmine (Mestinon): Report of a Possible First Case.
    Singh G; Hodgson T; Clarke DE
    Perm J; 2017; 21():15-240. PubMed ID: 28080955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful desensitization protocol for pyridostigmine hypersensitivity in a patient with myasthenia gravis.
    Aung T; Dowden AY
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):308. PubMed ID: 23535103
    [No Abstract]   [Full Text] [Related]  

  • 12. Pyridostigmine-Induced Bradycardia in Patient With MuSK-Ab-Positive Myasthenia Gravis and Alopecia Universalis.
    Nazari F; Abdi S
    J Clin Neuromuscul Dis; 2017 Sep; 19(1):49-50. PubMed ID: 28827491
    [No Abstract]   [Full Text] [Related]  

  • 13. Ipratropium in patients with COPD receiving cholinesterase inhibitors.
    Liggett SB; Daughaday CC; Senior RM
    Chest; 1988 Jul; 94(1):210-2. PubMed ID: 2968227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse interaction between corticosteroid hormones and anticholinesterase drugs.
    Patten BM; Oliver KL; Engel WK
    Trans Am Neurol Assoc; 1973; 98():248-52. PubMed ID: 4784943
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful desensitization protocol for pyridostigmine in a 12 year old patient with myasthenia gravis.
    Kaplan F; Topal E
    Turk J Pediatr; 2023; 65(2):326-329. PubMed ID: 37114698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of myasthenia gravis with cholinesterase inhibitors--principles and pharmacologic monitoring].
    Henze T
    Fortschr Neurol Psychiatr; 1996 Mar; 64(3):110-21. PubMed ID: 8900891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary vasospasm secondary to hypercholinergic crisis: an iatrogenic cause of acute myocardial infarction in myasthenia gravis.
    Comerci G; Buffon A; Biondi-Zoccai GG; Ramazzotti V; Romagnoli E; Savino M; Rebuzzi AG; Biasucci LM; Loperfido F; Crea F
    Int J Cardiol; 2005 Sep; 103(3):335-7. PubMed ID: 16098399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celebrating the 70 years of pyridostigmine on therapy of Myasthenia Gravis: historical aspects of the preliminary trials.
    Lorenzoni PJ; Kay CSK; Ducci RD; Fustes OJH; Werneck LC; Scola RH
    Arq Neuropsiquiatr; 2020 Mar; 78(3):179-181. PubMed ID: 32215460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spurious hyperchloremia and hyperbicarbonatemia in a patient receiving pyridostigmine bromide therapy for myasthenia gravis.
    Wacks I; Oster JR; Pérez GO; Kett DH
    Am J Kidney Dis; 1990 Jul; 16(1):76-9. PubMed ID: 2368710
    [No Abstract]   [Full Text] [Related]  

  • 20. Coexistence of Parkinson's disease and myasthenia gravis: a case report.
    Kao KP; Kwan SY; Lin KP; Chang YC
    Clin Neurol Neurosurg; 1993 Jun; 95(2):137-9. PubMed ID: 8344012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.